Man Xu

28 papers receiving 706 citations

Peers

Man Xu
Comparison fields: 5 of 95
  • Cardiology and Cardiovascular Medicine 166
  • Cancer Research 103
  • Complementary and alternative medicine 50
  • Pharmacology 47
  • Molecular Biology 355
Replace Lu Gao with:
Lu Gao China
Aiying Li China
Meiling Yan China
Chunpeng Zou China
Kyuho Jeong South Korea
Quanxing Wang China
Jiang Zou China
Hongxia Yang China
Man Xu relative to Lu Gao China Lu Gao's profile →
Citations per field
00.5×1.7×
Lu Gao · 1×
Citations per year

Countries citing papers authored by Man Xu

Since Specialization
Citations

This map shows the geographic impact of Man Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Xu more than expected).

Fields of papers citing papers by Man Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Xu. The network helps show where Man Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Man Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Man Xu Line = papers co-authored together Man Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201578
2 201967
3 202165
4 201763
5 201851
6 201949
7 201935
8 202434
9 202025
10 202225
11 201724
12 201924
13 202223
14 202122
15 202018
16 201717
17
Salvianolate inhibits proliferation and endothelin release in cultured rat mesangial cells.
200117
18 202014
19 201912
20 202210

About Man Xu

Man Xu is a scholar working on Geriatrics and Gerontology, Complementary and alternative medicine, Cardiology and Cardiovascular Medicine, Cancer Research and Ophthalmology, having authored 29 papers that have together received 713 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (7 papers), Signaling Pathways in Disease (4 papers), Tissue Engineering and Regenerative Medicine (3 papers), Corneal Surgery and Treatments (3 papers), Ocular Surface and Contact Lens (3 papers), Corneal surgery and disorders (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (166 citations), Cancer Research (103 citations), Complementary and alternative medicine (50 citations), Pharmacology (47 citations) and Molecular Biology (355 citations). Man Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qizhu Tang, Sihui Huang, Qingqing Wu, Wei Deng, Chun‐Xia Wan, Di Fan, Hai‐Ming Wu, Libo Liu, Zhen‐Guo Ma and Hai‐Han Liao. Their work appears in journals such as International Journal of Molecular Medicine, Molecular Microbiology, Acta Pharmaceutica Sinica B, Scientific Reports and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026